MAR vs ZYME · P/E 32, rev $26.19B vs rev $76.3M
Marriott International Inc (MAR) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the MAR and ZYME stock pages for the full models.
Not investment advice.